CA-15.3
₹1500
This assay is useful for predicting early recurrence in women treated for Carcinoma Breast. It is specially useful for serial testing in women with prior Stage II / III breast cancer who are clinically free of disease.
Test information: Fasting not necessary, but preferred
Reporting: Within 48 hours*
- Fasting is not necessary but preferred.
* For details, please see service-related policies
Talk to Health Expert
Health Articles
Diabetes Symptoms in Young Adults: When to Get Te…
📅 18 Apr, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP
PCOS in Women: Symptoms, Diagnosis, and Treatment…
📅 18 Apr, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP
थायरॉइड विकार: लक्षण, प्रकार और आवश्यक जांच
📅 17 Apr, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP
Fatty Liver Disease: Causes, Symptoms, and Diagno…
📅 17 Apr, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP